Howard Hughes Medical Institute and Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195
In Xenopus embryos, -catenin has been
shown to be both necessary and sufficient for the establishment of dorsal cell fates. This signaling activity is
thought to depend on the binding of
-catenin to members of the Lef/Tcf family of transcription factors and
the regulation of gene expression by this complex. To
test whether
-catenin must accumulate in nuclei to establish dorsal cell fate, we constructed various localization mutants that restrict
-catenin to either the plasma
membrane, the cytosol, or the nucleus. When overexpressed in Xenopus embryos, the proteins localize as predicted, but surprisingly all forms induce an ectopic
axis, indicative of inducing dorsal cell fates. Given this
unexpected result, we focused on the membrane-tethered form of
-catenin to resolve the apparent discrepancy between its membrane localization and the hypothesized role of nuclear
-catenin in establishing dorsal cell fate. We demonstrate that overexpression of
membrane-tethered
-catenin elevates the level of free
endogenous
-catenin, which subsequently accumulates in nuclei. Consistent with the hypothesis that it is
this pool of non-membrane-associated
-catenin that signals in the presence of membrane-tethered
-catenin, overexpression of cadherin, which binds free
-catenin, blocks the axis-inducing activity of membrane-
tethered
-catenin. The mechanism by which ectopic
membrane-tethered
-catenin increases the level of endogenous
-catenin likely involves competition for the
adenomatous polyposis coli (APC) protein, which in
other systems has been shown to play a role in degradation of
-catenin. Consistent with this hypothesis, membrane-tethered
-catenin coimmunoprecipitates with
APC and relocalizes APC to the membrane in cells.
Similar results are observed with ectopic plakoglobin,
casting doubt on a normal role for plakoglobin in axis
specification and indicating that ectopic proteins that
interact with APC can artifactually elevate the level of
endogenous
-catenin, likely by interfering with its degradation. These results highlight the difficulty in interpreting the activity of an ectopic protein when it is assayed in a background containing the endogenous
protein. We next investigated whether the ability of
-catenin to interact with potential protein partners in
the cell may normally be regulated by phosphorylation.
Compared with nonphosphorylated
-catenin,
-catenin phosphorylated by glycogen synthase kinase-3 preferentially associates with microsomal fractions expressing the cytoplasmic region of N-cadherin. These results
suggest that protein-protein interactions of
-catenin can be influenced by its state of phosphorylation, in addition to prior evidence that this phosphorylation modulates the stability of
-catenin.
The binding of Given this proposed model of the role of Expression Constructs
All green fluorescent protein (GFP) and myc-tagged APC-GFP was produced by PCR amplifying the central portion of a
human APC cDNA (amino acids 1013-2026; full-length human APC cDNA was kindly provided by Ray White, University of Utah, Salt Lake
City, UT) and subcloning this fragment into a CS2+/GFP vector resulting
in a fusion protein with GFP at the carboxy terminus.
The myc-tagged human plakoglobin construct was kindly provided by
Michael Klymkowsky (University of Colorado, Boulder, CO) (Merriam et
al., 1997 Microinjection of Synthetic RNAs and Embryo Culture
Capped synthetic RNAs encoding each of the constructs used in this study
were prepared with the Message Machine kit (Ambion, Inc., Austin, TX).
For axis duplication experiments, 250 pg of each RNA was injected into
the two ventral blastomeres at the four-cell stage, and embryos were
reared to stage 40, at which time they were scored for the presence or absence of a secondary dorsal axis. For Western blot and immunoprecipitation experiments, 1-2 ng of the indicated RNAs were injected into all four
blastomeres at the four-cell stage, and embryos were cultured at room
temperature to stage 7. For intracellular localization experiments, 1-2 ng of the indicated RNAs were injected into the animal pole of blastomeres at the two- to four-cell stage, and embryos were cultured to either stage 9 or 10. Where indicated, 10,000-mol wt Oregon Green dextran (1 mg/ml final concentration; Molecular Probes, Eugene, OR) was coinjected as a lineage tracer.
Animal Cap Explants and Confocal Microscopy
Animal cap explants were fixed in 4% paraformaldehyde-PBS for 1-2 h
at room temperature followed by two washes in PBS + 0.2% Triton X-100
(PBT). After fixation, explants to be stained for endogenous Confocal microscopy was performed with a scan head (model MRC-600; Bio-Rad Labs, Hercules, CA) attached to a microscope (model Optiphot-2; Nikon, Inc., Melville, NY). All images were collected with a 60×
1.4 NA PlanApo objective. Multicolor images were collected sequentially
with the appropriate filter blocks to ensure that there was no bleed
through between channels. Images were processed using Adobe Photoshop software (San Jose, CA).
Western Blot and Immunoprecipitation
To compare differences in the steady-state levels of endogenous To determine if the ectopic TM- Rabbit Reticulocyte Lysate Assays
RNAs encoding To determine whether phosphorylated Intracellular Distribution and Signaling Activity of
To determine the intracellular localization of each mutant construct, Xenopus animal cap cells expressing each
GFP-tagged form of
The intracellular distribution observed for each localization mutant of Table I.
Frequency of Axis Duplication by -CATENIN is a multifunctional protein involved in both
the regulation of intercellular adhesion and cell signaling
during development (for reviews see Miller and Moon,
1996
; Peifer, 1995
). These functions are dependent on interactions between
-catenin and various protein partners,
including members of the cadherin superfamily of cell adhesion molecules (for review see Kemler, 1993
; Peifer,
1995
), the adenomatous polyposis coli (APC)1 protein
(Rubinfeld et al., 1993
; Su et al., 1993
), and members of
the Lef/Tcf family of transcription factors (Behrens et al., 1996
; Molenaar et al., 1996
). Each of these interactions occurs in a distinct subcellular compartment and reflects different activities of
-catenin in each compartment of the
cell.
-catenin to Lef/Tcf transcription factors
and their translocation into the nucleus may play an essential role in controlling the transcription of genes required
for specification of cell fate during early development of
Xenopus (Behrens et al., 1996
; Molenaar et al., 1996
; Larabell et al., 1997
) and Drosophila (Brunner et al., 1997
;
Riese et al., 1997
; van de Wetering et al., 1997
). In Xenopus embryos, recent studies demonstrate that there are
dorso-ventral asymmetries in both the levels and subcellular localization of
-catenin in cleavage stage blastomeres
(Larabell et al., 1997
). Since an amino-terminal site of
-catenin is required for its maximal in vitro phosphorylation by glycogen synthase kinase 3 (GSK-3) and mutation
of this site stabilizes
-catenin, it has been hypothesized
that the dorso-ventral differences in
-catenin levels arise
from lower GSK-3 activity on the prospective dorsal side
of the embryo, resulting in an increase in the pool of dorsal
-catenin (Yost et al., 1996
; Larabell et al., 1997
). The
mechanism underlying this process may also involve the
stabilization of interactions between
-catenin and APC
that has been shown to occur in response to Wnt signals in
cultured cells (Papkoff et al., 1996
). Since the interaction
of APC with
-catenin is strongly linked to the regulation
of steady-state
-catenin levels (Munemitsu et al., 1995
;
Papkoff et al., 1996
; Hayashi et al., 1997
), stabilization of
-catenin/APC complexes might saturate a rate-limiting
step in a degradative pathway and result in the accumulation of newly synthesized
-catenin in the cytosol on the
dorsal side of the embryo (Larabell et al., 1997
). The elevated dorsal pool of
-catenin would then undergo translocation into the nucleus, perhaps via interactions with
Lef/Tcf transcription factors (Behrens et al., 1996
; Molenaar et al., 1996
). The presence of
-catenin in nuclei of
dorsal but not ventral blastomeres presages and likely contributes directly to the activation of dorsal-specific genes
at the onset of zygotic transcription (Larabell et al., 1997
),
and the products of these genes then work in a combinatorial manner with other signal transduction pathways to
specify dorsal cell fate (for review see Kimelman et al.,
1992
).
-catenin in
the establishment of dorsal cell fates, we sought to test a
prediction of this model: Specification of dorsal cell fate
requires the accumulation of
-catenin in nuclei rather
than in the cytoplasm or at membranes. Without such information one cannot exclude the possibility that
-catenin induces dorsal cell fate by acting in other cellular compartments in which it is found, such as in the cytoplasm or
at the plasma membrane (for review see Miller and Moon,
1996
). Testing this relationship has recently gained importance for a second reason. Ectopic expression of plakoglobin in Xenopus embryos leads to its accumulation in nuclei
and the induction of dorsal cell fate as observed with
-catenin. Surprisingly, a form of plakoglobin that cannot enter
nuclei is also active in promoting dorsal cell fate, and the
authors conclude that it functions by anchoring XTcf-3 or
a related factor from acting as a repressor of dorsal cell
fate (Merriam et al., 1997
). By analyzing the signaling activities of localization mutants of
-catenin, their affects
on steady-state levels of endogenous
-catenin, and their
effects on the subcellular localization of endogenous
-catenin, APC, and XTcf-3, we have reached an alternative conclusion. Our results are most consistent with the hypothesis that
-catenin functions in the specification of dorsal cell fate in Xenopus in a manner dependent upon its
entry into the nucleus.
MATERIALS AND METHODS
-catenin constructs
were produced by PCR amplification of full-length wild-type
-catenin
and subcloning of the resulting PCR product into the CS2+ vector upstream from, and in frame with, either a c-myc epitope (Evan et al., 1985
)
or GFP (S65T mutant; Heim et al., 1995
). Both the nuclear exclusion sequence (NES) and nuclear localization sequence (NLS) localization mutants were produced by subcloning sequences encoding either the nuclear
exclusion sequence of rabbit pkI (Wen et al., 1994
, 1995
) or the nuclear localization sequence of the SV-40 large T-antigen (Kalderon et al., 1984
;
Lanford and Butel, 1984
) in frame with the NH2 terminus of
-catenin.
Both the NES and NLS oligos contained a consensus Kozak sequence
(Kozak, 1984
) followed by an AUG translation initiation site. The transmembrane
-catenin mutant was produced by subcloning a fragment of
Xenopus N-cadherin (Detrick et al., 1990
) that encodes the translation
start site, signal sequence, and transmembrane (TM) domain in frame
with the NH2 terminus of wt-
-catenin-GFP. TM-
-catenin 1-9 was produced by PCR amplifying repeats 1-9 of
-catenin and subcloning this
fragment in frame to the N-cadherin transmembrane. TM-
-catenin 1-myc
was produced by subcloning the N-cadherin TM domain in frame into an
XhoI site of wt-
-catenin-myc.
) and the HA-tagged XTcf-3 construct was generously provided
by Olivier Destree (Hubrecht Laboratory, Utrecht, The Netherlands)
(Molenaar et al., 1996
).
-catenin
were washed in MeOH, bleached in 50% MeOH, 30% H2O2, 20% DMSO
overnight at room temperature, and washed twice in MeOH. GFP-labeled
explants were not bleached because the bleaching process eliminates GFP
fluorescence. Antibody staining was performed in PBT supplemented
with 10% goat serum. Antihuman c-myc 9E10 monoclonal supernatant
was used at a 1:20 dilution, and anti-
-catenin polyclonal antibodies (Yost
et al., 1996
) were used at a 1:500 dilution. After incubation with the primary antibody, explants were washed three times in PBT and incubated
overnight at 4°C with a 1:250 dilution of Cy-3-conjugated secondary antibody (Jackson ImmunoResearch, West Grove, PA) in PBT supplemented
with 10% goat serum. After three washes in PBT, explants were mounted
in Vectashield (Vector Laboratories, Burlingame, CA).
-catenin
protein in response to injection of control RNA (GFP) or membrane-tethered
-catenin RNA, 25 injected embryos at stage 7 were homogenized in
RIPA buffer (10 mM Hepes, pH 7.4, 150 mM NaCl, 2 mM EGTA, 2 mM
EDTA, 1% Triton X-100, 0.5% Na deoxycholate, 0.1% SDS, 1 mM
PMSF, 1 µg/ml leupeptin) at 4°C. Lysates were cleared by spinning for 15 min at 15,000 rpm in a microcentrifuge. An aliquot of this lysate was collected and represents total (T) protein. The remainder of the cleared
lysate was incubated with ConA-Sepharose beads (Pharmacia LKB Biotech., Piscataway, NJ) for 1 hour at 4°C to remove all cadherin-bound
-catenin. The resulting supernatant contains the soluble (S), cytoplasmic
or nuclear, pool of
-catenin. Protein samples were analyzed by SDS-PAGE, and blots were probed with anti-
-catenin (1:1,000) and anti-
spectrin (1:1,000; Giebelhaus et al., 1987
) antibodies. Immunoblots were
then probed with a HRP-conjugated goat anti-rabbit secondary antibody
(1:10,000; Jackson ImmunoResearch). The HRP signal was visualized by
enhanced chemiluminescence (Amersham Corp., Arlington Heights, IL).
Signals for
-catenin and
-spectrin were quantitated from scanned images using NIH Image. Endogenous
-catenin levels (total and soluble)
from control-injected and TM-
-catenin-injected embryos were compared after normalization to
-spectrin. Levels of
-catenin in controls
was set to 1.0 and levels in TM-
-catenin-injected embryos are expressed
relative to this scale.
-catenin interacts with endogenous
APC and a cadherin fraction, we performed immunoprecipitation and
ConA precipitation analyses. Stage 7 embryos previously injected with
1.25 ng TM-
-catenin 1-myc were homogenized in lysis buffer (10 mM
Tris, pH 7.4, 150 mM NaCl, 2 mM EDTA, 0.5% NP-40, 1 mM PMSF, 1 µg/ml leupeptin) at 4°C. A cleared lysate was prepared by spinning the
crude homogenates at 15,000 rpm for 15 min in a microcentrifuge. For
APC immunoprecipitation, the cleared lysate was precleared for 1 h at
4°C with protein A-Sepharose beads to eliminate proteins that bind nonspecifically to the beads. The lysates were then incubated with anti-APC
polyclonal antibodies (Näthke et al., 1996
) bound to protein A-Sepharose
beads or control protein A-Sepharose beads for 1 h at 4°C. After five
washes in lysis buffer, samples were resuspended in SDS sample buffer.
For ConA precipitation, cleared lysates were incubated with ConA-Sepharose beads or control Sepharose beads for 1 h at 4°C. After five
washes, the bound proteins were solubilized with SDS sample buffer. Protein samples were analyzed by SDS-PAGE, and blots were probed with anti-myc antibodies (1:50) and HRP-conjugated goat anti-mouse secondary antibodies (Jackson ImmunoResearch) to detect the presence of
TM-
-catenin 1-myc in the samples. To determine levels of endogenous
-catenin present in APC and ConA precipitates, we probed blots with
anti-
-catenin antibodies as described above.
-catenin and Xenopus N-cadherin (Detrick et al., 1990
)
were transcribed in vitro using a Message Machine kit (Ambion, Inc.). A
rabbit reticulocyte lysate was used with RNAs translated individually for
60 min at 30°C. The
-catenin reactions were supplemented with [35S]methionine and then centrifuged (4°C) after translation for 15 min. Xenopus
N-cadherin RNA was translated using nonradioactive methionine in the
presence of canine pancreatic microsomes (Promega Corp., Madison,
WI). To test
-catenin binding to N-cadherin, 25-µl aliquots of translations of microsomes with or without N-cadherin were mixed with 15-µl reactions of
-catenin translations, followed by addition of ATP to 0.4 mM.
Samples were incubated for 3.5 h at (4°C) on a rotator to allow binding to
membranes. Samples were centrifuged for 15 min at 20,000 g (4°C) and
then pelleted microsomes were carefully rinsed with reticulocyte lysate
lacking labeled protein. Pellets and aliquots of the supernatant were diluted with SDS gel sample buffer.
-catenin would interact with
microsomes in the presence of N-cadherin, RNAs were translated as
described above except that nonradioactive methionine replaced the
[35S]methionine. 60 µl of microsome translations conducted in the presence or absence of N-cadherin RNA were mixed with 50 µl of translations
of precentrifuged
-catenin. Assay tubes were then supplemented with 50 µCi
of [
32P]ATP, and ~0.1 U of recombinant Xenopus glycogen synthase kinase-3 (Xgsk-3) where indicated. After 20 min at 30°C to facilitate phosphorylation, samples were rotated for 3 h at 4°C to allow binding to microsomes and then centrifuged for 20 min at 20,000 g. The supernatants and pellets were subjected to immunoprecipitation with a rabbit polyclonal antibody to
-catenin, followed by separation on SDS 10% polyacrylamide gels and autoradiography.
RESULTS
-Catenin Localization Mutants
-catenin is a multifunctional protein that is localized to
several intracellular compartments, including the plasma
membrane, cytosol, and nucleus (for review see Miller and
Moon, 1996
). The localization of
-catenin to each of
these compartments is thought to reflect the interaction of
-catenin with various protein partners and the different
functions of
-catenin in cell adhesion and signal transduction. Recent studies have suggested that the signaling function of
-catenin may be linked to accumulation of
-catenin-Lef/Tcf complexes in nuclei (Behrens et al., 1996
;
Molenaar et al., 1996
). Although these studies suggest that
the signaling function of
-catenin is carried out in the nucleus, we sought to directly test where in the cell
-catenin
is required to have signaling activity. We therefore constructed a series of
-catenin localization mutants that
contain additional sequences that target the resulting fusion proteins to a specific subcellular compartment (Fig. 1 A). Each fusion protein was tagged with GFP (S65T mutant; Heim et al., 1995
) so that its intracellular localization
could be easily determined by confocal microscopy. The
wild-type (WT)-
-catenin-GFP construct was prepared as
a control and was expected to mimic both the localization
and function of endogenous
-catenin in various subcellular compartments. NES-
-catenin-GFP is a mutant that
contains the nuclear exclusion sequence of rabbit pkI at the NH2 terminus (Wen et al., 1994
, 1995
). This mutant
was expected to mimic the functions of cytosolic and membrane-bound
-catenin and would help test the requirement of nuclear localization for the signaling function of
-catenin. NLS-
-catenin-GFP is a mutant that contains
the nuclear localization signal of the SV-40 large T-antigen
(Kalderon et al., 1984
; Lanford and Butel, 1984
) fused to
the NH2 terminus of
-catenin. This protein was expected
to localize exclusively to nuclei and was produced to test
the requirement for either cytosolic or membrane-localized
-catenin in signal transduction. Finally, TM-
-catenin is a mutant that contains the signal sequence and transmembrane domain of Xenopus N-cadherin fused to the
NH2 terminus of
-catenin. This construct was produced to restrict
-catenin to membranes and, similar to the
NES-
-catenin construct, would test whether nuclear localization is required for the signaling function of
-catenin.
Fig. 1.
Schematic representation of constructs used in this
study. (A) Diagrams depicting the structure of wild-type and localization mutant -catenin proteins. Some constructs were
tagged at the COOH terminus with either GFP (S65T mutant;
Heim et al., 1995
) or a c-myc epitope (Evan et al., 1985
). Shadowed boxes represent the 13 Arm repeats with a nonrepeat sequence between repeats 10 and 11. Sequences directing
-catenin
to specific intracellular compartments were added to the NH2 terminus of both wild-type and truncated forms of
-catenin. Wild-type human plakoglobin possesses an overall structure identical
to that of
-catenin and is tagged at the NH2 terminus with a c-myc
epitope (Merriam et al., 1997
). (B) Linear representation of wild-type human APC protein showing conserved motifs, including
the oligomerization domain, Arm repeats, 15- and 20-amino acid
repeats, microtubule binding domain (MT binding), and discs
large binding domain (Dlg binding). The central portion of APC,
which is sufficient for
-catenin binding and downregulation
(Munemitsu et al., 1995
), was tagged at the COOH terminus with
GFP (S65T mutant; Heim et al., 1995
).
[View Larger Version of this Image (43K GIF file)]
-catenin were examined by confocal
microscopy. WT-
-catenin-GFP accumulates at the plasma
membrane, in the cytosol, and in the nucleus (Fig. 2 A).
This pattern is identical to that seen for endogenous
-catenin in animal cap cells (Yost et al., 1996
), demonstrating that the GFP tag does not influence the subcellular localization of the
-catenin fusion protein. NES-
-catenin-GFP is found predominantly in the cytoplasm and at
the plasma membrane, although low levels of GFP fluorescence are detected in the nucleus (Fig. 2 B). The NLS-
-catenin-GFP fusion protein is localized almost exclusively to
nuclei, although faint fluorescence is detected in association with the plasma membrane (Fig. 2 C). TM-
-catenin- GFP is localized to intracellular vesicles and organelles predictive of its association with the endoplasmic reticulum
and Golgi apparatus (Fig. 2 D). TM-
-catenin-GFP was
never detected in the nucleus.
Fig. 2.
Localization of wild-type and mutant -catenin-GFP
proteins in animal cap cells. The
intracellular distribution of each
mutant was determined by confocal microscopy (A-D). The WT-
-catenin-GFP protein (A) is localized to the plasma membrane,
cytosol, and nucleus in a pattern
indistinguishable from that seen
for endogenous
-catenin protein
(Yost et al., 1996
). NES-
-catenin-GFP (B) is present at plasma
membrane and at high levels in
the cytoplasm. Low levels of fluorescence are detected in the nucleus, which likely reflects the fact
that the NES domain does not inhibit nuclear entry but instead
promotes the rapid export of
tagged proteins from the nucleus.
NLS-
-catenin-GFP (C) is predominantly found in the nucleus,
and very little fluorescence is observed in the cytoplasm or in association with the plasma membrane.
The TM-
-catenin-GFP mutant
(D) localizes to intracellular vesicles and organelles in apparent association with the endoplasmic
reticulum and Golgi apparatus.
TM-
-catenin-GFP fluorescence
was never detected in the nucleus.
[View Larger Version of this Image (170K GIF file)]
-catenin matched our predictions and,
therefore, allowed us to test whether the signaling activity
of
-catenin is dependent on its subcellular localization.
The signaling activity of
-catenin can be assayed by determining its ability to induce a secondary axis after overexpression in ventral blastomeres (Funayama et al., 1995
),
as also observed with other components of the Wnt-1 signaling pathway (for review see Moon et al., 1997
). Therefore, synthetic RNAs encoding each localization mutant
were injected into the marginal zone of each ventral blastomere at the four-cell stage, and embryos were scored at
stage 40 for the presence or absence of a secondary embryonic axis. Given the recent demonstration that
-catenin
interacts with members of the Lef/Tcf family of transcription factors (Behrens et al., 1996
; Molenaar et al., 1996
),
we predicted that both the NES and TM mutants, which
do not accumulate in nuclei, would be inactive in the axis
duplication assay, whereas the WT and NLS mutants
would cause axis duplication. In contrast to these predictions, we found that overexpression of any of the localization mutants resulted in embryos with secondary axes (Table I) suggesting that the translocation of ectopic
-catenin into the nucleus may not be required for the establishment
of dorsal cell fates.
-Catenin
Localization Mutants
The Signaling Activity of the TM--Catenin Mutant
Is Suppressed by Overexpression of Cadherin
One interpretation of the axis duplication results is that
the signaling activity of -catenin is independent of its localization in the cell, consistent with the observation that a
membrane-tethered form of plakoglobin is also able to induce an axis duplication (Merriam et al., 1997
). Another
possible interpretation, however, is that the ectopic
-catenin competes with endogenous
-catenin for access to the
machinery that regulates steady-state levels of
-catenin.
This hypothetical competition could lead to the elevation
of endogenous
-catenin levels that could engage in signaling activities. To distinguish between these possibilities, we took advantage of the observation that overexpression
of C-cadherin can suppress the signaling activity of
-catenin by anchoring
-catenin to the membrane (Fagotto et
al., 1996
). Therefore, we prepared a deletion mutant of
TM-
-catenin that lacks the amino terminus, Arm repeats
10-13, and the carboxy terminus (Fig. 1 A, TM-
-catenin
1-9). This mutant lacks the region necessary for C-cadherin binding but retains the region required for APC
binding (Fagotto et al., 1996
). The rationale for this experiment is that if the TM-
-catenin 1-9 mutant is directly involved in establishing dorsal cell fates, then overexpression of C-cadherin should not be able to suppress its
signaling activity. However, if the TM-
-catenin 1-9 mutant is functioning indirectly by elevating a free, signaling pool of endogenous
-catenin, overexpression of C-cadherin should be able to suppress axis duplication by sequestering endogenous
-catenin to the plasma membrane. Therefore, RNA encoding TM-
-catenin 1-9 was
injected into ventral blastomeres in the presence or absence of C-cadherin RNA, and embryos were scored at
stage 40 for duplication of the embryonic axes (Table II).
Overexpression of TM-
-catenin 1-9 in ventral blastomeres resulted in the induction of secondary axes at very
high frequency (Table II). In contrast, coinjection of C-cadherin completely suppressed the ability of TM-
-catenin 1-9 to induce secondary axes. This result demonstrates
that the TM-
-catenin mutant lacks signaling activity, defined as an ability to induce an ectopic embryonic axis, under conditions (overexpression of C-cadherin) where endogenous
-catenin is sequestered to the plasma membrane.
Table II.
C-cadherin Inhibits the Ability of TM- |
Overexpression of the TM--Catenin Mutant Results
in Stabilization of Endogenous
-Catenin
To test whether the overexpression of TM--catenin
causes a stabilization of endogenous
-catenin in the cytosol and nucleus, we extracted protein from embryos injected with control GFP RNA or TM-
-catenin RNA and
performed immunoblot analyses to determine the relative
levels of endogenous
-catenin in both total (T) and soluble
(S) protein fractions (Fig. 3). Soluble fractions represent
lysates that have been incubated with ConA-Sepharose beads, which bind many membrane glycoproteins, including
all cadherins (Fagotto et al., 1996
). Thus,
-catenin present
in the supernatant after incubation with ConA beads represents the soluble, non-cadherin-bound pool of
-catenin
in the cell. This procedure allowed us to estimate the relative distribution of endogenous
-catenin in total homogenates (Fig. 3, T) and soluble, non-cadherin-bound pools
(Fig. 3, S). Protein samples were analyzed by SDS-PAGE,
and blots were probed with anti-
-catenin and anti-
-spectrin antibodies. We found that overexpression of either
TM-
-catenin 1-myc or TM-
-catenin 1-9 results in an
approximate twofold increase in total (T) and an approximate three- to fourfold increase in soluble (S) levels of endogenous
-catenin after normalizing
-catenin to levels of
-spectrin (numbers below each lane represent relative
levels of
-catenin in TM-
-catenin-injected embryos
compared to GFP-injected controls). The ability of both
TM-
-catenin mutants to stabilize endogenous
-catenin
was confirmed in a second, independent experiment (data
not shown). Thus, overexpression of TM-
-catenin results in the elevation of both total and soluble pools of endogenous
-catenin.
Overexpression of the TM--Catenin Mutant Results in
Accumulation of Endogenous
-Catenin in Nuclei
Given that the TM--catenin mutant appears to signal by
elevating a free, signaling pool of endogenous
-catenin,
we sought to determine whether overexpression of TM-
-catenin results in the accumulation of endogenous
-catenin in nuclei in a manner similar to that seen after inhibition of GSK-3 (Yost et al., 1996
) and activation of Wnt
signaling (Larabell et al., 1997
). Therefore, we overexpressed several mutant
-catenin constructs and examined the distribution of endogenous
-catenin in animal caps by
confocal microscopy. Since our anti-
-catenin antibody
recognizes the NH2-terminal domain (Yost et al., 1996
),
we used TM-
-catenin mutants that lack the NH2-terminal domain to distinguish endogenous
-catenin protein
from ectopic
-catenin proteins. We found that overexpression of TM-
-catenin 1-9 resulted in the increased accumulation of endogenous
-catenin in nuclei (Fig. 4, A-F).
Specifically, after injection of TM-
-catenin we observed
that a subset of animal cap cells show elevated levels of endogenous
-catenin in nuclei (Fig. 4, A and D, arrowheads).
Since a fluorescent lineage tracer (Oregon green dextran
[OGDx]; Fig. 4, B and E) was coinjected with the RNA, simultaneous analysis of cells possessing elevated nuclear
-catenin and the lineage tracer (Fig. 4, C and F) reveals a
direct correspondence between the presence of TM-
-catenin and accumulation of endogenous
-catenin in the nucleus. Neighboring cells not receiving TM-
-catenin 1-9
RNA do not show high levels of endogenous
-catenin in
the nucleus (Fig. 4, A, C, D, and F, arrows). In addition, a
small percentage of cells (~10%) that received TM-
-catenin RNA also does not show high levels of endogenous
-catenin in the nucleus. The reason for this result is unclear, but it may simply represent differences in the responsiveness of individual cells to TM-
-catenin expression,
variations in the levels of TM-
-catenin RNA received by
each cell, or cell cycle differences in the levels of endogenous
-catenin in the nucleus. The effect of overexpression of TM-
-catenin on the localization of endogenous
-catenin was confirmed in four separate experiments in
which ~15 animal cap explants were analyzed. Identical
results to those presented in Fig. 4 were also obtained with
a TM-
-catenin
N mutant, which only lacks the amino-terminal domain (data not shown). In contrast to the effect
of TM-
-catenin expression on nuclear
-catenin levels,
injection of a control RNA encoding
-catenin
N-9 (Fig.
1 A), a mutant that lacks the NH2-terminal domain and
Arm repeats 1-9 and is not active in the axis duplication assay (data not shown), does not affect levels of endogenous
-catenin in the nucleus (Fig. 4, G-I). Thus, ectopic
expression of
-catenin causes an unsuspected accumulation of endogenous
-catenin in nuclei, similar to overexpression of activators of the Wnt pathway (Schneider et
al., 1996
; Yost et al., 1996
; Larabell et al., 1997
). The simplest explanation is that ectopic
-catenin present in the cytoplasm or even at membranes competes with endogenous
-catenin for access to the degradative machinery, resulting in the stabilization and accumulation of endogenous
-catenin in the nucleus, a hypothesis tested below.
TM--Catenin Competes with Endogenous
-Catenin for Interactions With Endogenous
APC and a Cadherin Fraction
Both APC and cadherin are potential regulators of the signaling function of -catenin (for review see Miller and
Moon, 1996
) and, therefore, are candidates to play a role
in the stabilization of endogenous
-catenin after overexpression of TM-
-catenin. To test whether TM-
-catenin
binds endogenous APC and cadherin, protein lysates extracted from embryos injected with TM-
-catenin 1-myc
RNA were subjected to immunoprecipitation with anti-APC antibodies (Fig. 5 A, APC-IP) and ConA precipitation (Fig. 5 A, ConA, represents cadherin-bound
-catenin). The association of TM-
-catenin 1-myc with APC
and the ConA fraction containing cadherins was then assayed by immunoblotting with anti-myc antibodies. We found that TM-
-catenin 1-myc coimmunoprecipitated
with APC (Fig. 5 A, APC-IP) and was also present in the
ConA precipitates that contain cadherins (Fig. 5 A,
ConA). TM-
-catenin 1-myc is not detected in lysates incubated with beads alone, demonstrating the specificity of
both precipitations (Fig. 5 A, beads). Thus, ectopic TM-
-catenin interacts with endogenous APC and is present in
a fraction that contains cadherins. Given this result, we
asked whether the binding of TM-
-catenin to APC and
its association with a fraction that contains cadherins reduces the levels of endogenous
-catenin associated with
APC and the cadherin fraction. Protein extracts from embryos injected with either a control RNA or TM-
-catenin
1-myc were subjected to immunoprecipitation with anti-APC antibodies (Fig. 5 B) or ConA precipitation (Fig. 5
C), and the levels of endogenous
-catenin were subsequently determined by immunoblotting with anti-
-catenin antibodies. We observed that overexpression of TM-
-catenin 1-myc results in a decrease in the steady-state
levels of endogenous
-catenin associated with APC (Fig.
5 B) and a cadherin fraction (Fig. 5 C). The levels of endogenous
-catenin that coimmunoprecipitate with APC
after overexpression of TM-
-catenin 1-myc were found
to decrease approximately threefold relative to control
levels in two experiments and decreased approximately
1.2-fold in a third experiment. Levels of endogenous
-catenin associated with a cadherin fraction after overexpression of TM-
-catenin 1-myc were found to decrease to ~0.6 of
control levels in each of three experiments. These data
suggest that the binding of ectopic
-catenin to both APC
and cadherin results in a decrease in the binding of endogenous
-catenin to each protein and the accumulation of a
free, signaling pool of endogenous
-catenin in the cell.
Overexpression of the TM--Catenin Mutant Results
in the Relocalization of APC
To further examine the ability of TM--catenin mutants
to compete for interactions with APC, a protein thought to
be involved in regulating the stability of
-catenin in cells
(Munemitsu et al., 1995
; Papkoff et al., 1996
), we investigated whether overexpression of TM-
-catenin can affect
the localization of APC in the cell. We attempted to examine
the effect of TM-
-catenin expression on the localization
of endogenous APC but were unsuccessful in obtaining
any specific staining in animal cap cells using the anti-APC
antibodies from two different sources (Rubinfeld et al., 1993
; Näthke et al., 1996
). Therefore, to perform this experiment we constructed an APC deletion mutant that
contains the
-catenin-binding sites that are necessary and
sufficient to promote the rapid degradation of
-catenin in
cultured cells (Munemitsu et al., 1995
) and fused this mutant to GFP to facilitate visualization of the fusion protein by confocal microscopy (Fig. 1 B, APC-GFP). Analysis of
cells expressing APC-GFP demonstrated that this protein
is distributed uniformly throughout the cytoplasm and is
absent from the nucleus (Fig. 6 A). Coexpression of TM-
-catenin 1-9 resulted in the dramatic redistribution of
APC-GFP (Fig. 6 B) to a pattern similar to that seen for
TM-
-catenin GFP (see Fig. 2 D). Overexpression of
TM-
-catenin 1-9 did not affect the localization of control GFP protein (data not shown), demonstrating the specificity of its affect on the distribution of APC-GFP. Experiments using an myc-tagged TM-
-catenin construct (Fig. 1
A, TM-
-catenin 1-myc) further demonstrate that the distribution of the membrane-tethered
-catenin protein
(Fig. 6 D) and that of APC-GFP (Fig. 6 C) completely overlap (yellow represents overlapping staining; Fig. 6 E).
These data strongly suggest that ectopic
-catenin mutants
interact with APC, a component of the degradative machinery. Such interactions may reduce the ability of endogenous
-catenin to interact with endogenous or ectopic
APC, resulting in its stabilization and increased availability for signaling.
Overexpression of Plakoglobin Results
in the Accumulation of Endogenous -Catenin
in the Nucleus and the Relocalization
of APC-GFP in the Cytoplasm
Plakoglobin is closely related to -catenin, and like
-catenin, ectopic plakoglobin accumulates in nuclei and can induce a secondary axis when overexpressed in Xenopus
embryos (Karnovsky and Klymkowsky, 1995
). Given that
plakoglobin interacts with many of the same protein partners as
-catenin, we hypothesized that ectopic plakoglobin may compete with endogenous
-catenin for interactions with these protein partners resulting in the formation of a free, signaling pool of endogenous
-catenin in a manner similar to that seen after overexpression of the membrane-tethered
-catenin. To test this possibility, we investigated whether overexpression of plakoglobin (Fig. 1 A,
h-plakoglobin) alters the distribution of endogenous
-catenin in animal cap cells. We injected RNA encoding myc-tagged plakoglobin into the animal pole of blastomeres at the four-cell stage and examined the distribution of both
endogenous
-catenin (Fig. 7, A and C) and ectopic plakoglobin (Fig. 7, B and C) in animal cap cells. Ectopic myc-tagged plakoglobin accumulated in the cytoplasm of animal cap cells but was not seen in nuclei (Fig. 7, B and C).
Visualization of endogenous
-catenin in the same cells
(Fig. 7, A and C) revealed that elevated levels of endogenous
-catenin were present in nuclei of cells that possessed ectopic plakoglobin (Fig. 7, A and C, arrowheads),
whereas no such elevation was apparent in cells that do
not possess ectopic plakoglobin (Fig. 7, A and C, arrows).
Therefore, overexpression of plakoglobin results in the accumulation of endogenous
-catenin in nuclei. These data
are consistent with the idea that the observed signaling activity of plakoglobin may be attributable, at least in part,
to the formation of a free, signaling pool of endogenous
-catenin that accumulates in the nucleus to affect target
gene expression. Importantly, we observe the accumulation of endogenous
-catenin in the nucleus at levels of injected plakoglobin RNA (1-2 ng) that are less than was
used by Karnovsky and Klymkowsky (1995)
to establish
the axis-inducing activity of plakoglobin.
The effect of overexpression of plakoglobin on the intracellular distribution of endogenous -catenin prompted
us to ask whether ectopic plakoglobin can sequester APC
as we had shown for membrane-tethered
-catenin. Coexpression of myc-tagged plakoglobin and APC-GFP resulted
in a dramatic change in the localization of APC-GFP
(compare Fig. 7 F to control localization shown in Fig. 7
D) to a pattern identical to that of plakoglobin (Fig. 7 G).
Superimposing the individual images confirms the colocalization of plakoglobin and APC-GFP in cells (arrows mark
overlapping staining that appears yellow in Fig. 7 H).
These data strongly suggest that ectopic plakoglobin interacts with APC, an important regulator of
-catenin stability. This situation may result in competition between ectopic plakoglobin and endogenous
-catenin for binding
to APC, leading to an increase in a free, signaling pool of
-catenin that accumulates in the nucleus.
Different Phosphorylation Isoforms of -Catenin
Compete for Interactions With Cadherin
The above experiments suggest that ectopic -catenin
competes with endogenous
-catenin, leading to the accumulation of endogenous
-catenin in nuclei. This result
raises the question of whether competition exists normally
between endogenous pools of
-catenin in the cell. We hypothesized that besides promoting
-catenin/Armadillo degradation (Peifer et al., 1994
; Yost et al., 1996
), GSK-3
might also modulate the interaction of
-catenin with cadherins at the plasma membrane. Consistent with this idea,
both tyrosine- and serine/threonine-phosphorylated forms
of Armadillo preferentially associate with membrane fractions compared to soluble, cytosolic fractions in Drosophila embryos (Peifer et al., 1994
). To address this hypothesis,
we investigated whether phosphorylation of
-catenin by
Xgsk-3 changes the association of
-catenin with N-cadherin in vitro. In control experiments, we found that 35S-labeled
-catenin specifically bound to microsomal membranes containing N-cadherin (compare Fig. 8 A, lanes 2 and 3) in
reticulocyte lysates. In these experiments, we also determined that the unbound
-catenin present in the supernatant (Fig. 8 A, lane 1) reflected a 12-18-fold excess relative
to that bound to the N-cadherin microsomes in the pellet
(Fig. 8 A, lane 2).
We then exploited the excess of -catenin in the supernatant relative to that bound to cadherin in the reticulocyte lysate binding assay to directly test whether the phosphorylation of
-catenin by Xgsk-3 altered its ability to
bind microsomes expressing N-cadherin. The assays were
conducted in the presence of [
32P]ATP, which was added
to the reticulocyte lysate to facilitate detection of phosphoproteins, and all samples were immunoprecipitated with an anti-
-catenin antibody to specifically monitor
phosphorylated
-catenin. When
-catenin RNA is cotranslated with Xgsk-3 RNA, then bound to microsomes expressing N-cadherin, most of the phosphorylated
-catenin is associated with the microsomal pellet (Fig. 8 B, lane
5) rather than the supernatant (Fig. 8 B, lane 1), which contains the majority of the total
-catenin in this assay
(Fig. 8 A). The same results were obtained when recombinant Xgsk-3 protein was added to translations of
-catenin
(Fig. 8 B, lane 6, pellet, and lane 2, supernatant). The preferential association of phosphorylated
-catenin with N-cadherin containing microsomes is a specific interaction since
the amount of phosphorylated
-catenin in the microsomal pellet was reduced and the amount in the supernatant increased, by omission of N-cadherin from the assay (Fig.
8 B, lane 7, pellet, and lane 3, supernatant). Omission of
Xgsk-3 from the assay (Fig. 8 B, lane 8, pellet, and lane 4,
supernatant) also results in a decrease in the N-cadherin-
bound
-catenin relative to that present in the supernatant, demonstrating that phosphorylation of
-catenin by
Xgsk-3, and not kinases that may be present in reticulocyte lysates, is responsible for the observed increase in the
association of phosphorylated
-catenin with N-cadherin. Since phosphorylated
-catenin is primarily associated
with the microsomal membranes in a cadherin-dependent
manner under conditions where the majority of
-catenin
remains in the postmicrosomal supernatant (Fig. 8 A),
these data strongly suggest that phosphorylation of
-catenin by Xgsk-3 enhances its association with the cytoplasmic domain of cadherins. In Fig. 8 and in independent experiments, we observed that the total level of phosphorylated
-catenin (estimated by the combined levels in both the
supernatant and pellet lanes) was somewhat greater in the
presence relative to the absence of N-cadherin (data not
shown). This raises the questions of whether the phosphorylation of
-catenin occurs before, during, or after association with cadherins and whether the interaction of
-catenin with cadherin facilitates the process of phosphorylation or
decreases the degradation of the phosphorylated
-catenin.
In independent experiments, we asked if recombinant
-catenin, phosphorylated in vitro by recombinant Xgsk-3,
preferentially associates with N-cadherin-GST fusion protein bound to glutathione beads. Consistent with the conclusions reported here, we find that under conditions
where the majority of the
-catenin is not phosphorylated
and is not bound to the cadherin beads (i.e.,
-catenin is
present in excess) the phosphorylated form of
-catenin is preferentially bound to the cadherin beads (Torres, M.,
and R.T. Moon, unpublished data).
The function of -catenin in specifying dorsal cell fate in
Xenopus embryos may be dependent on interactions with
Lef/Tcf transcription factors and the accumulation of
-catenin-Lef/Tcf complexes in the nucleus, where they positively regulate expression of dorsal-specific genes (for review
see Moon et al., 1997
). In support of this hypothesis,
-catenin is detected in nuclei of dorsal but not ventral blastomeres at the 16-32-cell stages of Xenopus (Larabell et
al., 1997
) and after zygotic transcription has commenced at
the late blastula stage (Schneider et al., 1996
). Moreover,
several recent studies have demonstrated that both
-catenin and Armadillo can function as a transcriptional activator when complexed to Lef/Tcf transcription factors (Molenaar et al., 1996
; Korinek et al., 1997
; Morin et al., 1997
;
van de Wetering et al., 1997
). Taken together, these data
have led to the hypothesis that the signaling function of
-catenin in establishing the dorsal axis in Xenopus embryos is dependent on its nuclear localization. Although
many lines of evidence support this idea, several observations raise questions regarding this proposed model of
-catenin signaling. Overexpression of
-catenin increases
gap junction permeability in the absence of transcription
(Guger and Gumbiner, 1995
), suggesting it is modulating
intercellular communication in a manner independent of
de novo transcription. In addition, overexpression of a
membrane-tethered form of plakoglobin that is unable to
enter nuclei results in the induction of an ectopic dorsal
axis (Merriam et al., 1997
), suggesting that the nuclear accumulation of endogenous
-catenin is not required to induce the expression of dorsal-specific genes. Given these
discrepancies in the proposed model of how
-catenin functions to establish dorsal cell fate, we have directly examined this issue and conclude that the signaling function
of
-catenin in axis specification is dependent on its localization to the nucleus. Our studies also present a clear cautionary note to all studies in which mutant proteins are
overexpressed in a wild-type background, as we show that
an unsuspected competition exists between ectopic and
endogenous proteins, resulting in functional activation of
the endogenous protein.
Is Nuclear -Catenin Required for the Induction of
Dorsal Cell Fate?
We targeted ectopic forms of -catenin to membranes, the
cytoplasm, or the nucleus to test whether the accumulation
of
-catenin in nuclei is required for its role in specifying
the dorso-ventral axis in Xenopus embryos. We show that
all of the localization mutants tested are active in inducing
an ectopic axis, suggesting at first glance that the signaling
activity of ectopically expressed
-catenin is not dependent on its localization to a specific subcellular compartment. The axis-inducing activity of the TM-
-catenin mutant was particularly perplexing given the proposed role of
nuclear
-catenin-Lef/Tcf complexes (Behrens et al., 1996
;
Huber et al., 1996
; Molenaar et al., 1996
; Brunner et al.,
1997
; Korinek et al., 1997
; Morin et al., 1997
; Riese et al.,
1997
; van de Wetering et al., 1997
). Therefore, we examined the mechanism underlying the signaling activity of
the membrane-tethered
-catenin and found that it acts
indirectly to specify dorsal cell fate by elevating the
steady-state levels of endogenous
-catenin, resulting in the accumulation of a signaling pool of
-catenin in the
nucleus. Several lines of evidence support this conclusion:
(a) Overexpression of C-cadherin completely blocks the
ability of the TM-
-catenin 1-9 to induce an ectopic axis
(Table II) despite the fact that the presence of Arm repeats 1-9 is not sufficient for C-cadherin binding (Fagotto
et al., 1996
). This result suggests that overexpression of
C-cadherin suppresses the axis-inducing activity of TM-
-catenin 1-9 by sequestering endogenous
-catenin to the
plasma membrane where it is unable to signal. (b) Overexpression of various TM-
-catenin mutants results in an approximate three- to fourfold increase in the steady-state
levels of endogenous
-catenin in non-cadherin-bound fractions (Fig. 3). This increase in the levels of soluble
-catenin is manifest by the accumulation of endogenous
-catenin in the nucleus (Fig. 4).
The mechanism by which overexpression of TM--catenin causes the observed stabilization of endogenous
-catenin may be the result of competition between ectopic and
endogenous
-catenin for binding to various protein partners, including APC and cadherin. Both APC and cadherin have been implicated in regulating the signaling activity of
-catenin and Armadillo (Munemitsu et al., 1995
;
Cox et al., 1996
; Fagotto et al., 1996
; Papkoff et al., 1996
;
Sanson et al., 1996
; Korinek et al., 1997
; Morin et al., 1997
;
Rubinfeld et al., 1997
) and, therefore, are candidates to
play a role in the stabilization of endogenous
-catenin after overexpression of TM-
-catenin. We show that ectopic
TM-
-catenin 1-myc protein interacts with endogenous
APC and with a cell fraction that contains cadherin and
that these interactions result in a decrease in the levels of
endogenous
-catenin associated with APC and cadherin (Fig. 5). Moreover, overexpression of various TM-
-catenin mutants dramatically alters the subcellular distribution
of ectopic APC (Fig. 6). This interaction with APC is
likely to be the most important factor in predicting the
ability of ectopic
-catenin to stabilize endogenous
-catenin and induce dorsal cell fate. Previous studies have
shown that the ability of various
-catenin deletion mutants to induce a secondary axis coincides with the ability
of each of these mutants to bind APC, while several of
these active mutants do not bind C-cadherin (Fagotto et
al., 1996
). Together, these results are consistent with the
idea that the ectopic
-catenin competes with endogenous
-catenin for binding to various protein partners, and in
particular APC. As APC is then unavailable for interactions with endogenous
-catenin to promote its degradation, endogenous
-catenin accumulates in the cell and is
available for signaling.
The data presented here, taken together with evidence
that -catenin interacts with Lef/Tcf transcription factors
(Behrens et al., 1996
; Huber et al., 1996
; Korinek et al.,
1997
; Molenaar et al., 1996
; Morin et al., 1997
; Rubinfeld
et al., 1997
; van de Wetering et al., 1997
) and that endogenous
-catenin accumulates in nuclei of dorsal but not
ventral blastomeres of cleavage stage Xenopus embryos
(Larabell et al., 1997
), strongly argue that the signaling activity of
-catenin is dependent on its translocation into
the nucleus. In the nucleus, it is likely that Lef/Tcf bind to
the promoters of specific genes, and
-catenin interacts
with these promoters indirectly through its binding to Lef/
Tcf, resulting in altered DNA bending and modulation of
gene expression (Behrens et al., 1996
). A likely target gene
of
-catenin-Lef/Tcf complexes is the dorsal regulatory
gene siamois, whose expression is induced in response to
Wnt (Carnac et al., 1996
; Yang-Snyder et al., 1996
) and
-catenin (Brannon and Kimelman, 1996
; Brannon et al.,
1997
).
Given the preponderance of evidence indicating that
-catenin mediates its signaling activity through interactions with Lef/Tcf transcription factors, one may question
the importance of our demonstrating that nuclear accumulation is necessary for the signaling activity of
-catenin. A
recent study by Merriam et al. (1997)
, however, demonstrates that overexpression of a membrane-tethered plakoglobin mutant in Xenopus embryos results in the induction of an ectopic secondary axis. In contrast to our
conclusion regarding the function of TM-
-catenin, these
authors argue that the membrane-tethered plakoglobin induces an ectopic dorsal axis by anchoring in the cytoplasm
a negative regulator of dorsal cell fate, hypothesized to be
XTcf-3 or a related factor, thereby blocking its inhibitory function in the nucleus (Merriam et al., 1997
). This interpretation suggests that the result of Wnt signaling through
-catenin or its ortholog plakoglobin is to inactivate an inhibitor of dorsal cell fate instead of a model where
-catenin or plakoglobin functions in concert with Lef/Tcf transcription factors to activate downstream target genes. Our
data are not consistent with the hypothesis of Merriam and
colleagues since we find that ectopic membrane-tethered
-catenin, and by extension membrane-tethered plakoglobin, function indirectly by elevating levels of endogenous
-catenin in the cell. Similarly, we find that overexpression
of plakoglobin in Xenopus animal cap cells results in the
accumulation of endogenous
-catenin in the nucleus (Fig.
7) and that ectopic plakoglobin alters the distribution of
APC (Fig. 7), a regulator of
-catenin stability and
-catenin-Lef/Tcf transcriptional activity (Munemitsu et al., 1995
;
Papkoff et al., 1996
; Hayashi et al., 1997
; Korinek et al., 1997
;
Morin et al., 1997
). These data are most consistent with
the idea that ectopic plakoglobin saturates available APC-binding sites, reducing the interaction of endogenous
-catenin with APC, resulting in the stabilization of endogenous
-catenin. Finally, we have found that TM-
-catenin does
not sequester XTcf-3, a potential regulator of dorsal-specific gene expression (Molenaar et al., 1996
), in the cytoplasm
(data not shown). Thus, it seems unlikely that the related
form of membrane-tethered plakoglobin (Merriam et al.,
1997
) would be active in axis induction by anchoring XTcf-3 or a related inhibitory factor to the plasma membrane.
Our data, however, do not rule out the possibility that
XTcf-3 normally acts as a transcriptional repressor when
bound to DNA on its own and that the binding of
-catenin to XTcf-3 relieves this inhibition and instead promotes
transcription (Brannon et al., 1997
). In summary, we suggest that gain-of-function assays with plakoglobin are difficult to interpret because of the unanticipated effects on
endogenous
-catenin and APC described above. These
data taken together with the recent observation that depletion of plakoglobin transcripts in early Xenopus embryos
does not inhibit the development of dorsal cell fates (Kofron
et al., 1997
) suggest that plakoglobin is not a necessary contributor to the signaling events involved in axis specification.
Implications of Competition between Ectopic
and Endogenous -Catenin on Interpretations of
Overexpression Studies in Xenopus Embryos
Our analyses of the function of TM--catenin raise a very
important caveat of overexpression analyses in Xenopus
embryos. We demonstrate that overexpression of TM-
-catenin causes the elevation of a free, signaling pool of
endogenous
-catenin, and it is this endogenous pool that
is active in inducing an ectopic dorsal axis. Given this result, we hypothesize that the signaling activity of various
-catenin mutants (Fagotto et al., 1996
) or plakoglobin
mutants (Merriam et al., 1997
) may be indirect, functioning by elevating levels of endogenous
-catenin in the cell
(Fig. 9). In fact, a discrepancy exists in the literature regarding the signaling activity of various
-catenin mutants
(Funayama et al., 1995
; Fagotto et al., 1996
) and similar
mutants in Armadillo (Orsulic and Peifer, 1996
), the
Drosophila homologue of
-catenin. For example, a mutant form of
-catenin lacking both the amino and carboxyl terminus induces a secondary dorsal axis when overexpressed in Xenopus embryos (Funayama et al., 1995
),
yet a similar mutant form of Armadillo is unable to transduce the Wingless signal in Drosophila embryos (Peifer
and Wieschaus 1990
; Orsulic and Peifer 1996
). Moreover,
a recent study has demonstrated that the carboxy-terminal domain of
-catenin and Armadillo constitutes a transactivation domain that is required for Lef/Tcf-dependent transcriptional activation (van de Wetering et al., 1997
). Although
-catenin and Armadillo possess very similar
functional domains, it remains possible that this disparity
in the signaling activity of various
-catenin and Armadillo mutants may be an actual difference between the
functional domains required for this activity. On the other hand, this difference could be resolved by arguing that ectopically expressed
-catenin acts indirectly by competing
with endogenous
-catenin for interactions with APC, a
potential component of the degradative machinery. This
competition would result in the stabilization of a free, signaling pool of endogenous
-catenin. In fact, examination
of the published data regarding the axis-inducing activity
of various
-catenin mutants shows that the ability of a
given ectopically expressed
-catenin mutant to induce
dorsal cell fate corresponds with its ability to bind APC
(Funayama et al., 1995
; Fagotto et al., 1996
). This conclusion calls into question the interpretation of many
-catenin overexpression studies performed in Xenopus embryos
and underscores the importance of determining the effects
of overexpression on the endogenous protein and protein partners with which the overexpressed protein may interact.
Implications of Competition between
Different Phosphorylation Isoforms of -Catenin
on the Regulation of
-Catenin
Distribution and Function
Given that ectopic and endogenous -catenin can compete
for binding to different protein partners, we asked whether
different phosphorylation isoforms of wild-type
-catenin
may also compete for interactions with one such protein
partner, N-cadherin. We demonstrate that phosphorylation of
-catenin by Xgsk-3 increases the ability of phosphorylated relative to nonphosphorylated
-catenin to
bind to microsomes containing the cytoplasmic domain of
N-cadherin. This result shows that competition between
different phosphorylation isoforms of
-catenin can occur
in vitro. Therefore, differential phosphorylation and competition may be an important mechanism by which cells
regulate the interaction of
-catenin with different partners, thereby determining its function and subcellular distribution. Consistent with this idea,
-catenin and Armadillo are often highly phosphorylated in cells, and the
regulation of tyrosine phosphorylation of
-catenin may
regulate adherens junction organization and cadherin function (for review see Miller and Moon, 1996
). Furthermore, both tyrosine- and serine/threonine-phosphorylated
forms of Armadillo preferentially associate with membrane fractions compared to soluble, cytosolic fractions
(Peifer et al., 1994
), consistent with the results presented
here and the evidence that cytoplasmic phosphorylated
-catenin is quickly targeted for degradation (Yost et al.,
1996
). In addition to promoting interactions with cadherin,
phosphorylation of
-catenin by Xgsk-3 or other intracellular kinases may also modulate the association of
-catenin with other protein partners, thereby regulating both
-catenin function and its subcellular distribution. Further
experiments will likely uncover possible connections between
-catenin phosphorylation and their effects on its
binding interactions with different protein partners.
Received for publication 6 May 1997 and in revised form 2 July 1997.
Address all correspondence to Randall T. Moon, Howard Hughes Medical Institute, Box 35370, Room K536C HSB, University of Washington, Seattle, WA 98195. Tel.: (206) 543-1722. Fax: (206) 616-4230. e-mail: rtmoon{at}u.washington.eduWe thank Cheng-Jung Lai for constructing the TM--catenin-GFP construct. We also thank Ray White for the human APC cDNA, Michael Klymkowsky (University of Colorado, Boulder, CO) for the myc-tagged plakoglobin construct, Inke Näthke (Stanford University, Stanford CA),
W. James Nelson (Stanford University), and Paul Polakis (Onyx Pharmaceuticals) for anti-APC antibodies, Olivier Destree (Hubrecht Laboratory) for the HA-tagged Xtcf-3 construct, and Cynthia Yost and David
Kimelman for Xgsk-3 protein and assistance in the analysis of the axis-inducing activity of TM-
-catenin. We thank Monica Torres for permission to
cite her unpublished data.
APC, adenomatous polyposis coli; GFP, green fluorescent protein; NES, nuclear exclusion sequence; NLS, nuclear localization sequence; TM, transmembrane; WT, wild-type; Xgsk-3, Xenopus glycogen synthase kinase-3.
1. |
Behrens, J.,
J.P. von Kries,
M. Kuhl,
L. Bruhn,
D. Wedlich,
R. Grosschedl, and
W. Birchmeier.
1996.
Functional interaction of ![]() |
2. | Brannon, M., and D. Kimelman. 1996. Activation of Siamois by the Wnt pathway. Dev. Biol. 180: 344-347 |
3. |
Brannon, M.,
M. Gomperts,
L. Sumoy,
R.T. Moon, and
D. Kimelman.
1997.
A
![]() |
4. | Brunner, E., O. Peter, L. Schweizer, and K. Basler. 1997. pangolin encodes a Lef-1 homologue that acts downstream of Armadillo to transduce the Wingless signal in Drosophila. Nature (Lond.). 385: 829-833 |
5. |
Carnac, G.,
L. Kodjabachian,
J.B. Gurdon, and
P. Lemaire.
1996.
The homeobox gene Siamois is a target of the Wnt dorsalisation pathway and triggers organiser activity in the absence of mesoderm.
Development (Camb.).
122:
3055-3065
|
6. | Cox, R.T., C. Kirkpatrick, and M. Peifer. 1996. Armadillo is required for adherens junction assembly, cell polarity, and morphogenesis during Drosophila embryogenesis. J. Cell Biol. 134: 133-148 [Abstract]. |
7. | Detrick, R.J., D. Dickey, and C.R. Kintner. 1990. The effects of N-cadherin misexpression on morphogenesis in Xenopus embryos. Neuron. 4: 493-506 |
8. | Evan, G.I., G.K. Lewis, G. Ransay, and J.M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc protooncogene product. Mol. Cell Biol. 5: 3610-3616 |
9. |
Fagotto, F.,
N. Funayama,
U. Gluck, and
B.M. Gumbiner.
1996.
Binding to cadherins antagonizes the signaling activity of ![]() |
10. |
Fagotto, F.,
K. Guger, and
B.M. Gumbiner.
1997.
Induction of the primary dorsalizing center in Xenopus by the Wnt/GSK/![]() |
11. |
Funayama, N.,
F. Fagotto,
P. McCrea, and
B.M. Gumbiner.
1995.
Embryonic
axis induction by the armadillo repeat domain of ![]() |
12. |
Giebelhaus, D.H.,
B.D. Zelus,
S.K. Henchman, and
R.T. Moon.
1987.
Changes
in expression of ![]() |
13. |
Guger, K.A., and
B.M. Gumbiner.
1995.
![]() |
14. |
Hayashi, S.,
B. Rubinfeld,
B. Souza,
P. Polakis,
E. Wieschaus, and
A.J. Levine.
1997.
A Drosophila homolog of the tumor suppressor gene adenomatous
polyposis coli down-regulates ![]() |
15. | Heim, R., A.B. Cubitt, and R.Y. Tsien. 1995. Improved green fluorescence. Nature (Lond.). 373: 663-664 |
16. |
Huber, O.,
R. Korn,
J. McLaughlin,
M. Ohsugi,
B.G. Herrmann, and
R. Kemler.
1996.
Nuclear localization of ![]() |
17. | Kalderon, D., B.L. Roberts, W.D. Richardson, and A.E. Smith. 1984. A short amino acid sequence able to specify nuclear location. Cell. 39: 499-509 |
18. | Karnovsky, A., and M.W. Klymkowsky. 1995. Anterior axis duplication in Xenopus induced by the overexpression of the cadherin-binding protein plakoglobin. Proc. Natl. Acad. Sci. USA. 92: 4522-4526 [Abstract]. |
19. | Kemler, R.. 1993. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 9: 317-321 |
20. |
Kimelman, D.,
J.L. Christian, and
R.T. Moon.
1992.
Synergistic principles of
development: overlapping patterning systems in Xenopus mesoderm induction.
Development (Camb.).
116:
1-9
|
21. |
Kofron, M.,
A. Spagnuolo,
M. Klymkowsky,
C. Wylie, and
J. Heasman.
1997.
The roles of maternal ![]() |
22. |
Korinek, V.,
N. Barker,
P.J. Morin,
D. van Wichen,
R. de Weger,
K.W. Kinzler,
B. Vogelstein, and
H. Clevers.
1997.
Constitutive transcriptional activation
by a ![]() ![]() ![]() |
23. | Kozak, M.. 1984. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 12: 857-872 [Abstract]. |
24. | Lanford, R.E., and J.S. Butel. 1984. Constructions and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell. 39: 801-813 . |
25. |
Larabell, C.A.,
M. Torres,
B.A. Rowning,
C. Yost,
J.R. Miller,
M. Wu,
D. Kimelman, and
R.T. Moon.
1997.
Establishment of the dorso-ventral axis in
Xenopus embryos is presaged by early asymmetries in ![]() |
26. | Merriam, J.M., A.B. Rubenstein, and M.W. Klymkowsky. 1997. Cytoplasmically-anchored plakoglobin induces a WNT-like phenotype in Xenopus. Dev. Biol. 185: 67-81 |
27. |
Miller, J.R., and
R.T. Moon.
1996.
Signal transduction through ![]() |
28. |
Molenaar, M.,
M. van de Wetering,
M. Oosterwegel,
J. Peterson,
Maduro,
S. Godsave,
V. Korinek,
J. Roose,
O. Destree, and
H. Clevers.
1996.
XTcf-3
transcription factor mediates ![]() |
29. | Moon, R.T., J.D. Brown, and M. Torres. 1997. Wnts modulate cell fate and behavior during vertebrate development. Trends Genet. 13: 157-162 |
30. |
Morin, P.J.,
A.B. Sparks,
V. Korinek,
N. Barker,
H. Clevers,
B. Vogelstein, and
K.W. Kinzler.
1997.
Activation of ![]() ![]() |
31. |
Munemitsu, S.,
I. Albert,
B. Souza,
B. Rubinfeld, and
P. Polakis.
1995.
Regulation of intracellular ![]() |
32. | Näthke, I.S., C.L. Adams, P. Polakis, J.H. Sellin, and W.J. Nelson. 1996. The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J. Cell Biol. 134: 165-179 [Abstract]. |
33. |
Orsulic, S., and
M. Peifer.
1996.
An in vivo structure-function study of Armadillo, the ![]() |
34. | Papkoff, J., B. Rubinfeld, B. Schryver, and P. Polakis. 1996. Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol. Cell Biol. 16: 2128-2134 [Abstract]. |
35. | Peifer, M.. 1995. Cell adhesion and signal transduction: the Armadillo connection. Trends Cell Biol. 5: 224-229 . |
36. | Peifer, M., and E. Wieschaus. 1990. The segment polarity gene armadillo encodes a functionally modular protein that is the Drosophila homolog of human plakoglobin. Cell. 63: 1167-1176 |
37. | Peifer, M., L.-M. Pai, and M. Casey. 1994. Phosphorylation of the Drosophila adherens junction protein Armadillo: roles for Wingless signal and Zeste-white 3 kinase. Dev. Biol. 166: 543-556 |
38. |
Peifer, M.,
D. Sweeton,
M. Casey, and
E. Wieschaus.
1994.
Wingless signal and
Zeste-white 3 kinase trigger opposing changes in the intracellular distribution of Armadillo.
Development (Camb.).
120:
369-380
|
39. | Riese, J., X. Yu, A. Munnerlyn, S. Eresh, S.-C. Hsu, R. Grosschedl, and M. Bienz. 1997. LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentapalegic. Cell. 88: 777-787 |
40. |
Rubinfeld, B.,
B. Souza,
I. Albert,
O. Muller,
S.H. Chamberlain,
F.R. Masiarz,
S. Munemitsu, and
P. Polakis.
1993.
Association of the APC gene product
with ![]() |
41. |
Rubinfeld, B.,
P. Robbins,
M. El-Gamil,
I. Albert,
E. Porfiri, and
P. Polakis.
1997.
Stabilization of ![]() |
42. | Sanson, B., P. White, and J.P. Vincent. 1996. Uncoupling cadherin-based adhesion from wingless signaling in Drosophila. Nature (Lond.). 383: 627-630 |
43. |
Schneider, S.,
H. Steinbeisser,
R.M. Warga, and
P. Hausen.
1996.
![]() |
44. | Su, L.K., B. Vogelstein, and K.W. Kinzler. 1993. Association of the APC tumor suppressor protein with catenins. Science (Wash. DC). 262: 1734-1737 |
45. | Torres, M.A., J.A. Yang, Snyder, S.M. Purcell, A.A. DeMarais, L.L. McGrew, and R.T. Moon. 1996. Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development. J. Cell Biol. 133: 1123-1137 [Abstract]. |
46. | van de Wetering, M., R. Cavallo, D. Dooijes, M. van Beest, J. van Es, J. Loureiro, A. Ypma, D. Hursh, T. Jones, A. Bejsovec, et al . 1997. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell. 88: 789-799 |
47. |
Wen, W.,
A.T. Harootunian,
S.R. Adams,
J. Feramisco,
R. Tsien,
J.L. Meinkoth, and
S.S. Taylor.
1994.
Heat-stable inhibitors of cAMP-dependent
protein kinase carry a nuclear export signal.
J. Biol. Chem.
269:
32214-32220
|
48. | Wen, W., J.L. Meinkoth, R.Y. Tsien, and S.S. Taylor. 1995. Identification of a signal for rapid export of proteins from the nucleus. Cell. 82: 463-473 |
49. | Yang-Snyder, J., J.R. Miller, J.D. Brown, C.-J. Lai, and R.T. Moon. 1996. A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr. Biol. 6: 1302-1306 |
50. |
Yost, C.,
M. Torres,
J.R. Miller,
E. Huang,
D. Kimelman, and
R.T. Moon.
1996.
The axis-inducing activity, stability, and subcellular distribution of ![]() |